Analysts Set Versigent (NYSE:VGNT) Target Price at $38.25

Versigent (NYSE:VGNT) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $38.25.

Several equities research analysts recently weighed in on the stock. Fox Advisors raised shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Wall Street Zen raised shares of Versigent to a “hold” rating in a research report on Saturday. TD Cowen initiated coverage on shares of Versigent in a report on Tuesday, April 14th. They issued a “buy” rating and a $47.00 target price for the company. UBS Group initiated coverage on shares of Versigent in a report on Tuesday, April 14th. They issued a “buy” rating and a $43.00 target price for the company. Finally, Royal Bank Of Canada initiated coverage on shares of Versigent in a report on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 target price for the company.

Versigent Stock Up 0.2%

Shares of Versigent stock opened at $34.78 on Friday. Versigent has a 52-week low of $26.34 and a 52-week high of $36.31.